Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 60 of 60 entries
View as:

Efficacy and Safety of Tildrakizumab in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Who Are Non-Responders to Dimethyl Fumarate Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04263610 Org: User:
Start: 09/04/19 End: 02/16/22 Due: 02/16/23

Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea Pedis

Phase: N/A Priority: Normal
NCT ID: NCT01096472 Org: User:
Start: 02/28/10 End: 06/30/10 Due: 06/30/11

Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis

Phase: N/A Priority: Normal
NCT ID: NCT05260073 Org: User:
Start: 03/09/22 End: 03/07/23 Due: 03/07/24

Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease

Phase: N/A Priority: Normal
NCT ID: NCT06488209 Org: User:
Start: 07/29/22 End: 12/31/24 Due: 12/31/25

A Single-dose, Randomised, Crossover, Placebo-controlled Study Assessing Two Fixed-dose Combinations of Inhaled Long-acting Beta-agonist and Corticosteroid

Phase: N/A Priority: Normal
NCT ID: NCT02094274 Org: User:
Start: 11/30/13 End: 05/31/14 Due: 05/31/15

LAS41005 in Hyperkeratotic Actinic Keratosis

Phase: N/A Priority: Normal
NCT ID: NCT01358851 Org: User:
Start: 04/30/11 End: 08/31/12 Due: 08/31/13

Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01628549 Org: User:
Start: 06/30/12 End: 01/31/13 Due: 01/31/14

A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses

Phase: N/A Priority: Normal
NCT ID: NCT05741294 Org: User:
Start: 01/20/23 End: 01/19/24 Due: 01/19/25

A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT06526182 Org: User:
Start: 07/03/24 End: 04/30/27 Due: 04/30/28

A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02413346 Org: User:
Start: 03/20/15 End: 08/26/16 Due: 08/26/17